Cwm LLC raised its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA – Free Report) by 49.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 1,267 shares of the company’s stock after buying an additional 420 shares during the period. Cwm LLC’s holdings in USANA Health Sciences were worth $68,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in USANA Health Sciences by 60.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after buying an additional 1,274 shares in the last quarter. Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the 3rd quarter valued at about $297,000. Louisiana State Employees Retirement System acquired a new position in shares of USANA Health Sciences in the 4th quarter worth approximately $300,000. Harbor Capital Advisors Inc. raised its holdings in shares of USANA Health Sciences by 32.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 6,282 shares of the company’s stock worth $337,000 after purchasing an additional 1,547 shares in the last quarter. Finally, Illinois Municipal Retirement Fund acquired a new stake in USANA Health Sciences during the third quarter valued at approximately $386,000. 54.25% of the stock is currently owned by institutional investors.
USANA Health Sciences Price Performance
USANA Health Sciences stock opened at $45.07 on Thursday. The firm’s 50 day simple moving average is $46.42 and its 200-day simple moving average is $48.05. The company has a market cap of $865.34 million, a P/E ratio of 14.04, a price-to-earnings-growth ratio of 1.38 and a beta of 0.94. USANA Health Sciences, Inc. has a fifty-two week low of $41.45 and a fifty-two week high of $69.60.
Analysts Set New Price Targets
USNA has been the topic of several research reports. DA Davidson dropped their price target on USANA Health Sciences from $48.00 to $46.00 and set a “neutral” rating on the stock in a report on Tuesday. StockNews.com raised USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Friday, January 12th.
Get Our Latest Stock Report on USNA
Insider Transactions at USANA Health Sciences
In other news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $49.05, for a total value of $257,022.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, COO Walter Noot sold 5,240 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $49.05, for a total transaction of $257,022.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total transaction of $178,707.74. The disclosure for this sale can be found here. Insiders have sold a total of 34,286 shares of company stock valued at $1,634,010 over the last ninety days. Corporate insiders own 0.33% of the company’s stock.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
- Five stocks we like better than USANA Health Sciences
- How to Most Effectively Use the MarketBeat Earnings Screener
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What Are Dividends? Buy the Best Dividend Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Low PE Growth Stocks: Unlocking Investment Opportunities
- PulteGroup Wins and Wins More on Interest Rate Cuts
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA – Free Report).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.